Compare ALZN & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALZN | NCRA |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 4.2M |
| IPO Year | 2021 | 2022 |
| Metric | ALZN | NCRA |
|---|---|---|
| Price | $1.19 | $0.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | 72.0K | ★ 8.0M |
| Earning Date | 03-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,627,944.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.84 | $0.09 |
| 52 Week High | $3.60 | $2.40 |
| Indicator | ALZN | NCRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 32.38 |
| Support Level | $1.03 | N/A |
| Resistance Level | $1.25 | $0.24 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 37.04 | 6.90 |
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.